Nkarta | BiotechTV

top of page

Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions

Mar 27

Company News

Nkarta CEO Paul Hastings on NK based cell therapies for autoimmune conditions

Paul Hastings describes why Nkarta believes NK based therapies are uniquely fit for this area.

BIO Chairman and Nkarta CEO talks biotech

Apr 27, 2023

Company News

BIO Chairman and Nkarta CEO talks biotech

Current BIO Chairman and Nkarta CEO Paul Hastings talks about the policy changes that have been affecting biotech lately, and NK cells.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh